BWI: GVK Biosciences Opens New Clinical Pharmacology Unit in Ahmedabad

Press release from Business Wire India
Source: GVK Biosciences Private Limited
Wednesday, March 17, 2010 11:30 AM IST (06:00 AM GMT)
Editors: General: Consumer interest; Business: Advertising, PR & marketing, Business services, Healthcare, biotechnology & pharmaceutical; Healthcare
--------------------------------------------------
GVK Biosciences Opens New Clinical Pharmacology Unit in Ahmedabad
New Facility Commissioned to Meet Increasing Business Demand

Hyderabad, Andhra Pradesh, India, Wednesday, March 17, 2010 -- (Business Wire India) -- GVK Biosciences (GVK BIO), Asia's leading contract research organization announced that it has commissioned its new clinical pharmacology unit (CPU) in Ahmedabad, India. The Ahmedabad CPU adds 110 beds to GVK BIO's existing capacity of 144 beds. The new CPU will conduct a variety of studies in healthy volunteers.

Ahmedabad was the most preferred and logical destination for expansion considering the volunteer pool accessibility and proximity to about 10 CROs and leading Pharma companies. With 3 clinical wards and 110 beds, the Unit is state-of-the-art and designed to suit all regulatory requirements. It also has special housing facilities for female volunteers. Key features of this Unit include access to special population like young women, post-menopausal women, diseased population and access to about 12,000 healthy volunteers.

GVK BIO's Clinical Pharmacology Unit (CPU) is a top service provider of bioequivalence studies to generic pharma companies globally. The CPU unit, operational from 2004 in Hyderabad, has undergone several international audits, inspections and has key accreditations to its credit including the USFDA, DCG(I), ANVISA (Brazil), AFSSAPS (France), WHO and the Ministry of Health, Turkey. In addition to the healthy volunteer population, the Ahmedabad facility gives access to diseased population in Psychiatry, Metabolism, Cardiovascular, Neurology etc.

"The opening of the new GVK BIO Clinical Pharmacology unit reflects our commitment to offer faster recruitment solutions to our customers. The facility has been audited by the DCGI and we have initiated our first study at the Ahmedabad facility", said Manni Kantipudi, President, GVK Biosciences.

About GVK BIO

GVK Biosciences (GVK BIO) is Asia's leading research services organization. GVK BIO provides a broad spectrum of services, stand‐alone and integrated, across the R&D value chain. GVK BIO's diverse portfolio of more than 100 customers includes Big Pharma, Agri & Life‐sciences companies, leading biotechs, generic pharma and academic institutions. Spread across five locations in India, GVK BIO is headquartered in Hyderabad, India and employs 1600+ people assisting clients to accelerate their research and success. Please write to bdcpu@gvkbio.com for slotting a Study.


CONTACT DETAILS
Sharada Alvakonda, GVK Biosciences Private Limited, +91 (40) 66929999/8, sharada@gvkbio.com

KEYWORDS
CONSUMER, MARKETING, BUSINESS SERVICES, HEALTHCARE, HEALTHCARE

If you wish to change your Business Wire India selection please click on this link http://www.businesswireindia.com/media/news.asp and use your personal username and password to login.

Submit your press release at http://www.businesswireindia.com